{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:18:40Z","timestamp":1794316720340,"version":"4.9.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Autonomic support of blood pressure increases with age in humans. Large differences exist in the dose of trimethaphan (TMP) required for ganglionic blockade in young and older women. We asked whether differences in the dose of TMP required to achieve ganglionic blockade are because of differences in the relative contributions of the sympathetic and parasympathetic nervous system in control of blood pressure with age. Muscle sympathetic nerve activity (microneurography, peroneal nerve), heart rate (HR), and blood pressure were recorded before and during incremental doses of TMP camsylate until ganglionic blockade was achieved (absence of muscle sympathetic nerve activity and &lt;5-bpm increase in HR during a valsalva maneuver; final TMP dose, 1\u20137 mg\/min). HR variability was analyzed from the ECG waveform (WinCPRS). The dose of TMP required to achieve ganglionic blockade is positively related to basal HR variability, where women with high HR variability require a higher dose of TMP to achieve ganglionic blockade. In contrast, baseline muscle sympathetic nerve activity is inversely related with the dose of TMP required to achieve ganglionic blockade, such that women with high basal muscle sympathetic nerve activity required a lower dose of TMP. As such, the change in HR with ganglionic blockade was positively related, and the change in mean arterial pressure was inversely related, with the dose of TMP required to achieve ganglionic blockade. These data suggest loss of parasympathetic tone and increased sympathetic tone with aging contribute to the increase in blood pressure with age in women and dictate the dose of TMP that is necessary to achieve ganglionic blockade.<\/jats:p>","DOI":"10.1161\/hypertensionaha.118.11550","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:01:11Z","timestamp":1539194471000},"page":"1236-1242","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in Women"],"prefix":"10.1161","volume":"72","author":[{"given":"Sarah E.","family":"Baker","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline K.","family":"Limberg","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle A.","family":"Dillon","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Curry","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Joyner","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne T.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00842.2012"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00036.2014"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP272167"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02393"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153864.24034.A6"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.099308"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.6.e3"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000084711.87421.07"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2011.224642"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.126391"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2011.212753"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.275.5.R1600"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2013.077248"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.190058"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100326"},{"key":"e_1_3_4_17_2","volume-title":"Drug Evaluations","author":"American Medical Association. Division of Drugs and Technology and American Society for Clinical Pharmacology and Therapeutics","year":"1986","unstructured":"American Medical Association. Division of Drugs and Technology and American Society for Clinical Pharmacology and Therapeutics. Drug Evaluations. 1986:1."},{"key":"e_1_3_4_18_2","volume-title":"Basic and Clinical Pharmacology 12\/E","author":"Katzung BG","year":"2012","unstructured":"Katzung, BG, Masters, S, Trevor, A. Basic and Clinical Pharmacology 12\/E: New York, NY: McGraw-Hill Education; 2012."},{"key":"e_1_3_4_19_2","unstructured":"Roche Laboratories. Product Information: Arfonad(R) Trimethaphan Camsylate. 1996."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP276440"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00331.2002"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-006-0387-7"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.93.5.1043"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00258"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2014.01040"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00554-8"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006971"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05179"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2011.01.008"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.056"},{"key":"e_1_3_4_31_2","first-page":"32","article-title":"Drugs for hypertensive emergencies.","volume":"31","year":"1989","unstructured":"Drugs for hypertensive emergencies. Med Lett Drugs Ther. 1989;31:32\u201334.","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_3_4_32_2","volume-title":"Goodman & Gilman\u2019s the PharmacologicalBasis of Therapeutics","author":"Goodman LS","year":"2001","unstructured":"Goodman, LS, Hardman, JG, Limbird, LE, Gilman, AG. Goodman & Gilman\u2019s the PharmacologicalBasis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001.","edition":"10"},{"key":"e_1_3_4_33_2","first-page":"107","article-title":"Treatment of hypertensive emergencies.","volume":"9","author":"Decarvalho JGR","year":"1979","unstructured":"Decarvalho, JGR, Messerli, FH, Frohlich, ED. Treatment of hypertensive emergencies. Drug Ther. 1979;9:107.","journal-title":"Drug Ther"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.118.11550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:59:09Z","timestamp":1715594349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.118.11550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.118.11550"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.118.11550","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2018-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}